{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T15:07:27Z","timestamp":1774105647766,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1006087","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000}}],"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T00:00:00Z","timestamp":1524096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004435","name":"Universidad de Navarra","doi-asserted-by":"publisher","award":["Research funds"],"award-info":[{"award-number":["Research funds"]}],"id":[{"id":"10.13039\/501100004435","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Agencia Estatal de Investigaci\u00f3n and FEDER funds","award":["MTM2016-79422-P"],"award-info":[{"award-number":["MTM2016-79422-P"]}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1006087","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T17:48:57Z","timestamp":1524160137000},"page":"e1006087","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Optimal dynamic control approach in a multi-objective therapeutic scenario: Application to drug delivery in the treatment of prostate cancer"],"prefix":"10.1371","volume":"14","author":[{"given":"Itziar","family":"Irurzun-Arana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvaro","family":"Janda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2827-5383","authenticated-orcid":true,"given":"Sergio","family":"Ardanza-Trevijano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3700-8658","authenticated-orcid":true,"given":"I\u00f1aki F.","family":"Troc\u00f3niz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,4,19]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0090-4295(03)00331-5","article-title":"Effective testosterone suppression for patients with prostate cancer: is there a best castration?","volume":"62","author":"MG Oefelein","year":"2003","journal-title":"Urology"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1200\/JCO.2007.12.4487","article-title":"Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group","volume":"26","author":"HI Scher","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1124\/jpet.112.195560","article-title":"Pharmacokinetic\/pharmacodynamic model of the testosterone effects of triptorelin administered in sustained release formulations in patients with prostate cancer","volume":"342","author":"E Romero","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"ref4","article-title":"Interdisciplinary Applied Mathematics","author":"H Sch\u00e4ttler","year":"2015"},{"key":"ref5","unstructured":"Bauer R. NONMEM users guide introduction to NONMEM 7.2. 0. ICON Development Solutions Ellicott City, MD. 2011;."},{"key":"ref6","article-title":"Optimal Control and Estimation","author":"RF Stengel","year":"2012"},{"key":"ref7","first-page":"196","article-title":"Optimization\u2014Theory and Applications. Applications of Mathematics","author":"L Cesari","year":"1983"},{"key":"ref8","article-title":"Optimization Methods for Engineering Design","volume":"5","author":"AR Parkinson","year":"2013","journal-title":"Brigham Young University"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0090-4295(00)00793-7","article-title":"Reassessment of the definition of castrate levels of testosterone: implications for clinical decision making","volume":"56","author":"MG Oefelein","year":"2000","journal-title":"Urology"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10479-011-0869-4","article-title":"A survey of optimization models on cancer chemotherapy treatment planning","volume":"221","author":"J Shi","year":"2014","journal-title":"Ann Oper Res"},{"key":"ref11","first-page":"91","article-title":"Recent Advances in Computational Optimization. Studies in Computational Intelligence","author":"P Drag","year":"2016"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10107-004-0559-y","article-title":"On the implementation of an interior-point filter line-search algorithm for large-scale nonlinear programming","volume":"106","author":"A W\u00e4chter","year":"2005","journal-title":"Math Program"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.compchemeng.2014.04.013","article-title":"Nonlinear modeling, estimation and predictive control in APMonitor","volume":"70","author":"JD Hedengren","year":"2014","journal-title":"Comput Chem Eng"},{"key":"ref14","article-title":"Applied Optimal Control: Optimization, Estimation and Control","author":"AE Bryson","year":"1975"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0025-5564(90)90021-P","article-title":"Role of optimal control theory in cancer chemotherapy","volume":"101","author":"GW Swan","year":"1990","journal-title":"Math Biosci"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1365-2125.2006.02820.x","article-title":"Population pharmacokinetic\/pharmacodynamic (PK\/PD) modelling of the hypothalamic\u2013pituitary\u2013gonadal axis following treatment with GnRH analogues","volume":"63","author":"CW Torn\u00f8e","year":"2007","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40262-015-0329-4","article-title":"Population Pharmacokinetic Analysis of Lanreotide Autogel\/Depot in the Treatment of Neuroendocrine Tumors: Pooled Analysis of Four Clinical Trials","volume":"55","author":"N Buil-Bruna","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-8945-0","article-title":"Optimal Control with Aerospace Applications","author":"JM Longuski","year":"2014"},{"key":"ref19","article-title":"Optimal Control Theory: Applications to Management Science and Economics","author":"SP Sethi","year":"2006"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1086\/260062","article-title":"The Pricing of Options and Corporate Liabilities","volume":"81","author":"F Black","year":"1973","journal-title":"J Polit Econ"},{"key":"ref21","article-title":"Optimal Control of Drug Administration in Cancer Chemotherapy","author":"R Martin","year":"1994"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF02462912","article-title":"Optimal control analysis in the chemotherapy of IgG multiple myeloma","volume":"39","author":"GW Swan","year":"1977","journal-title":"Bull Math Biol"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0025-5564(92)90038-X","article-title":"Optimal control of tumor size used to maximize survival time when cells are resistant to chemotherapy","volume":"110","author":"RB Martin","year":"1992","journal-title":"Math Biosci"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0025-5564(94)00027-W","article-title":"Drug kinetics and drug resistance in optimal chemotherapy","volume":"125","author":"MI Costa","year":"1995","journal-title":"Math Biosci"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0025-5564(00)00045-6","article-title":"Optimal control for a stochastic model of cancer chemotherapy","volume":"168","author":"AJ Coldman","year":"2000","journal-title":"Math Biosci"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Kimmel M, Swierniak A. Control Theory Approach to Cancer Chemotherapy: Benefiting from Phase Dependence and Overcoming Drug Resistance. In: Tutorials in Mathematical Biosciences III. Lecture Notes in Mathematics. Springer, Berlin, Heidelberg; 2006. p. 185\u2013221.","DOI":"10.1007\/11561606_5"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1142\/S0218339008002435","article-title":"Optimal Control of Mixed Immunotherapy and Chemotherapy of Tumors","volume":"16","author":"LG de Pillis","year":"2008","journal-title":"J Biol Syst"},{"issue":"10","key":"ref28","first-page":"291","article-title":"Dynamical Systems Properties of a Mathematical Model for the Treatment of CML","volume":"6","author":"U Ledzewicz","year":"2016","journal-title":"NATO Adv Sci Inst Ser E Appl Sci"},{"key":"ref29","article-title":"Optimal therapy regimens for treatment-resistant mutations of HIV","author":"W Gu","year":"2006"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s002850050076","article-title":"Optimal control of the chemotherapy of HIV","volume":"35","author":"D Kirschner","year":"1997","journal-title":"J Math Biol"},{"issue":"5","key":"ref31","first-page":"230","article-title":"A simplified control scheme for the Depth of Anesthesia","volume":"49","author":"J Almeida","year":"2016","journal-title":"IFAC-PapersOnLine"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Almeida J, Mendon\u00e7a T, Rocha P. A Simplified Control Approach for the Neuromuscular Blockade Level. In: CONTROLO 2016. Lecture Notes in Electrical Engineering. Springer, Cham; 2017. p. 37\u201344.","DOI":"10.1007\/978-3-319-43671-5_4"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.med.59.090506.155819","article-title":"The FDA Critical Path Initiative and Its Influence on New Drug Development","volume":"59","author":"J Woodcock","year":"2008","journal-title":"Annu Rev Med"},{"key":"ref34","first-page":"43","article-title":"Nonlinear Model Predictive Control. Communications and Control Engineering","author":"L Gr\u00fcne","year":"2011"},{"issue":"9","key":"ref35","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/bioinformatics\/18.9.1227","article-title":"Optimal enhancement of immune response","volume":"18","author":"RF Stengel","year":"2002","journal-title":"Bioinformatics"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mbs.2010.11.007","article-title":"Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function","volume":"229","author":"M Engelhart","year":"2011","journal-title":"Math Biosci"},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"e1005129","DOI":"10.1371\/journal.pcbi.1005129","article-title":"Optimized Treatment Schedules for Chronic Myeloid Leukemia","volume":"12","author":"Q He","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"ref38","article-title":"Theory of optimal experiments","author":"VV Fedorov","year":"1972"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/biomet\/84.2.429","article-title":"Optimal design in random-effects regression models","volume":"84","author":"F Mentr\u00e9","year":"1997","journal-title":"Biometrika"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1011035028755","article-title":"Optimal design of a population pharmacodynamic experiment for ivabradine","volume":"18","author":"SB Duffull","year":"2001","journal-title":"Pharm Res"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1006087","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1006087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:49:41Z","timestamp":1589010581000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1006087"}},"subtitle":[],"editor":[{"given":"James","family":"Gallo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,19]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1006087","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1006087","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,19]]}}}